The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock

Maya Guglin1, Carson Smith2, Roopa Rao2

  • 1Indiana University School of Medicine, Krannert Institute of Cardiology, 1801 Senate Blvd Suite 2000, Indianapolis, IN, 46202, USA. mguglin@gmail.com.

Heart Failure Reviews
|November 19, 2020
PubMed

Insights

Lupus myocarditis, a severe heart condition, is often overlooked when lupus is undiagnosed. Prompt diagnosis and specific treatments, including immunosuppression and advanced cardiac support, can be lifesaving.

Area of Science:

  • Cardiology
  • Rheumatology
  • Immunology

Background:

  • Lupus myocarditis is a rare but life-threatening cardiac manifestation of systemic lupus erythematosus.
  • It is frequently misdiagnosed, especially when presenting acutely without a prior lupus diagnosis.
  • Current management relies heavily on case reports and clinical expertise due to a lack of randomized controlled trials.

Purpose of the Study:

  • To review the diagnostic challenges and clinical presentation of lupus myocarditis.
  • To highlight cardiogenic shock as a critical manifestation of this condition.
  • To discuss current and emerging management strategies for lupus myocarditis.

Main Methods:

  • Literature review of lupus myocarditis, focusing on case reports and clinical experience.
  • Analysis of diagnostic criteria and clinical presentations.
  • Evaluation of treatment modalities, including immunosuppression and mechanical support.

Main Results:

  • Lupus myocarditis can present as acute or fulminant myocarditis, often mimicking other causes.
  • Cardiogenic shock is a significant and potentially fatal complication.
  • Effective management involves aggressive immunosuppression, mechanical circulatory support, and consideration for cardiac transplantation.

Conclusions:

  • Lupus myocarditis requires heightened clinical suspicion, particularly in cases of unexplained acute myocarditis.
  • Timely and specific treatment, including immunosuppressive therapy and advanced cardiac support, is crucial for improving outcomes.
  • Further research, including randomized controlled trials, is needed to optimize treatment protocols.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
119
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
191
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
324
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
198
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
117
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
234